American Journal of Cardiology
Volume 101, Issue 7 , Pages 947-952 , 1 April 2008

Long-Term Outcomes With Drug-Eluting Stents Versus Bare Metal Stents in the Treatment of Saphenous Vein Graft Disease (Results from the REgistro Regionale AngiopLastiche Emilia-Romagna Registry)

  • Luigi Vignali, MD

      Affiliations

    • Division of Cardiology, Azienda Ospedaliero Universitaria, Parma, Italy
    • Corresponding Author InformationCorresponding author: Tel: +39-0521-704313; fax: 39-0521-702189.
    • ,
  • Francesco Saia, MD

      Affiliations

    • Institute of Cardiology, University of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy
    • ,
  • Antonio Manari, MD

      Affiliations

    • Interventional Cardiology Unit, Santa Maria Nuova Hospital, Reggio Emilia, Italy
    • ,
  • Andrea Santarelli, MD

      Affiliations

    • Division of Cardiology, Infermi Hospital, Rimini, Italy
    • ,
  • Andrea Rubboli, MD

      Affiliations

    • Division of Cardiology, Maggiore Hospital, Bologna, Italy
    • ,
  • Elisabetta Varani, MD

      Affiliations

    • Division of Cardiology, Interventional Center, S. Maria delle Croci Hospital, Ravenna, Italy
    • ,
  • Giancarlo Piovaccari, MD

      Affiliations

    • Division of Cardiology, Infermi Hospital, Rimini, Italy
    • ,
  • Alberto Menozzi, MD

      Affiliations

    • Division of Cardiology, Azienda Ospedaliero Universitaria, Parma, Italy
    • ,
  • Gianfranco Percoco, MD

      Affiliations

    • Cardiac Catheterization Laboratory, S. Anna Hospital, Ferrara, Italy
    • ,
  • Alberto Benassi, MD

      Affiliations

    • Cardiac Catheterization Laboratory, Hesperia Hospital, Modena, Italy
    • ,
  • Guido Rusticali, MD

      Affiliations

    • Division of Cardiology, Guglielmo da Saliceto Hospital, Piacenza, Italy.
    • ,
  • Paolo Marzaroli, MSc

      Affiliations

    • Regional Health Care Agency, Emilia Romagna Region, Bologna, Italy
    • ,
  • Paolo Guastaroba, MSc

      Affiliations

    • Regional Health Care Agency, Emilia Romagna Region, Bologna, Italy
    • ,
  • Roberto Grilli, MD

      Affiliations

    • Regional Health Care Agency, Emilia Romagna Region, Bologna, Italy
    • ,
  • Aleardo Maresta, MD

      Affiliations

    • Division of Cardiology, Interventional Center, S. Maria delle Croci Hospital, Ravenna, Italy
    • ,
  • Antonio Marzocchi, MD

      Affiliations

    • Institute of Cardiology, University of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy

Received 12 July 2007 ,Revised 21 November 2007 ,Accepted 21 November 2007.

References 

  1. Bourassa MG, Fisher LD, Campeau L, Gillespie MJ, McConney M, Lesperance J. Long-term fate of bypass grafts: the Coronary Artery Surgery Study (CASS) and Montreal Heart Institute Experiences. Circulation. 1985;72(suppl):V71–V78
  2. FitzGibbon GM, Leach AJ, Kafka HP, Keon WJ. Coronary bypass graft fate: Long-term angiographic study. J Am Coll Cardiol. 1991;17:1975–1980
  3. Fitzgibbon GM, Kafka HP, Leach AJ, Keon WJ, Hooper GD, Burton JR. Coronary bypass graft fate and patients outcome: angiographic follow-up of 5,065 graft related to survival and reoperation in 1,388 patients during 25 years. J Am Coll Cardiol. 1996;28:616–626
  4. Savage MP, Douglas JS, Fischman DL, Pepine CJ, King SB, Werner JA, et al. Stent placement compared with balloon angioplasty for obstructed coronary bypass grafts (Saphenous Vein De Novo Trial Investigators). N Engl J Med. 1997;337:740–747
  5. Hanekamp CE, Koolen JJ, Den Heijer P, Schalij MJ, Piek JJ, Bär FW, et al. Randomized study to compare balloon angioplasty and elective stent implantation in venous bypass grafts: the Venestent study. Catheter Cardiovasc Interv. 2003;60:452–457
  6. Frimerman A, Rechavia E, Eigler N, Payton MR, Makkar R, Litvack F. Long-term follow-up of a high risk cohort after stent implantation in saphenous vein grafts. J Am Coll Cardiol. 1997;30:1277–1283
  7. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O’Shaughnessy C, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349:1315–1323
  8. Colombo A, Drzewiecki J, Banning A, Grube E, Hauptmann K, Silber S, et al. Randomized study to assess the effectiveness of slow-and moderate-release polymer-based paclitaxel-eluting stents for coronary artery lesion. Circulation. 2003;108:788–794
  9. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Eng J Med. 2002;346:1773–1780
  10. Stone GW, Ellis SG, Cox DA, Hermiller J, O’Shaughnessy C, Mann JT, et al. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med. 2004;350:221–231
  11. Keeley EC, Velez CA, O’Neill WW, Safian RD. Long-term clinical outcome and predictors of major adverse cardiac events after percutaneous interventions on saphenous vein graft. J Am Coll Cardiol. 2001;38:659–666
  12. Strauss BH, Serruys PW, Bertrand ME, Puel J, Meier B, Goy JJ, et al. Quantitative angiographic follow-up of the coronary Wallstent in native vessels and bypass graft. Am J Cardiol. 1992;69:475–481
  13. Safian RD, Kaplan B, Schreiber T, Waters J, Moses J, Leon MH. Final results of the randomized Wallstent endoprosthesis in saphenous vein graft trial (WINS). J Am Coll Cardiol. 1999;33(suppl):37A
  14. Ge L, Iakovou I, Sangiorgi GM, Chieffo A, Melzi G, Cosgrave J, et al. Treatment of saphenous vein graft lesions with drug-eluting stents. J Am Coll Cardiol. 2005;45:989–994
  15. Lee MS, Shah AP, Aragon J, Jamali A, Dohad S, Kar S, et al. Drug-eluting stenting is superior to bare metal stenting in saphenous vein grafts. Catheter Cardiovasc Interv. 2005;66:507–511
  16. Brunner-La Rocca HP, Kaiser C, Pfisterer M BASKET Investigators. Targeted stent use in clinical practice based on evidence from the BAsel Stent Cost Effectiveness Trial (BASKET). Eur Heart J. 2007;28:719–725
  17. Vermeersch P, Agostoni P, Verheye S, Van den Heuvel P, Convens C, Van den Branden F, et al. Increased late mortality after sirolimus-eluting stents versus bare-metal stents in diseased saphenous vein grafts: results from the randomized DELAYED RRISC Trial. J Am Coll Cardiol. 2007;50:261–267

PII: S0002-9149(07)02326-0

doi: 10.1016/j.amjcard.2007.11.055

American Journal of Cardiology
Volume 101, Issue 7 , Pages 947-952 , 1 April 2008

Article Tools

* Image Usage & Resolution